Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
NCT07297797

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

Led by Fujian Shengdi Pharmaceutical Co., Ltd. · Updated on 2026-01-26

234

Participants Needed

1

Research Sites

89 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to evaluate the efficacy and safety of HRS-9563 in patients with mild to moderate hypertension, and to explore its appropriate dosage.

CONDITIONS

Official Title

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • The subject voluntarily signs the informed consent form.
  • Male or female, aged 65 18 years and 64 75 years.
  • Patients with mild to moderate hypertension.
  • At screening and baseline, mean sitting office systolic blood pressure is > 130 mmHg.
  • At screening, 24-hour mean systolic blood pressure assessed by ABPM is 65 130 mmHg and < 160 mmHg.
Not Eligible

You will not qualify if you...

  • Secondary hypertension.
  • Orthostatic hypotension.
  • Type 1 diabetes or poorly controlled type 2 diabetes.
  • Any cardiovascular or cerebrovascular event within 6 months prior to screening.
  • Uncontrolled severe arrhythmia within 6 months prior to screening.
  • Suspected allergy to the investigational drug or its components.
  • Other diseases requiring Renin-Angiotensin-Aldosterone System inhibitor therapy besides hypertension.
  • Blood biochemical indicators during screening or baseline that do not meet exclusion standards.
  • Use of any medication affecting blood pressure within 4 weeks prior to screening or planned use during the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100029

Actively Recruiting

Loading map...

Research Team

Y

Yuhan Guo

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here